Treatment of testicular yolk sac carcinoma in the young child

William E Kaplan, C. F. Firlit

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The majority of testicular tumors in children will be of germ cell origin and the predominant pathologic type is the yolk sac carcinoma. Initial treatment of radical orchiectomy is not in question. However, because of its presumed less virulent character, especially in children less than 2 years old, confusion remains as to adjunctive treatment for yolk sac carcinoma. We have studied retrospectively 21 children with testis tumors encountered within the last 10 years. Of these cases 12 were classified pathologically as yolk sac carcinoma. All children were less than 3 years old and 10 of 12 were less than 2 years old. Of the 12 cases 4 had positive lymph node dissections and 3 of these 4 children were less than 2 years old. Although chemotherapy is so effective its toxicity cannot be minimized. Therefore, adjunctive chemotherapy should be reserved for those patients who have lymphatic spread. Young children with yolk sac tumors are not immune to metastatic disease and should be treated with an extended unilateral lymphadenectomy for staging and appropriate treatment regimens.

Original languageEnglish (US)
Pages (from-to)663-664
Number of pages2
JournalJournal of Urology
Volume126
Issue number5
DOIs
StatePublished - Jan 1 1981

Fingerprint

Yolk Sac
Carcinoma
Lymph Node Excision
Therapeutics
Endodermal Sinus Tumor
Drug Therapy
Orchiectomy
Testicular Neoplasms
Germ Cells
Testis
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Kaplan, William E ; Firlit, C. F. / Treatment of testicular yolk sac carcinoma in the young child. In: Journal of Urology. 1981 ; Vol. 126, No. 5. pp. 663-664.
@article{e0a98a1e8673484185cef3e0e2238ba4,
title = "Treatment of testicular yolk sac carcinoma in the young child",
abstract = "The majority of testicular tumors in children will be of germ cell origin and the predominant pathologic type is the yolk sac carcinoma. Initial treatment of radical orchiectomy is not in question. However, because of its presumed less virulent character, especially in children less than 2 years old, confusion remains as to adjunctive treatment for yolk sac carcinoma. We have studied retrospectively 21 children with testis tumors encountered within the last 10 years. Of these cases 12 were classified pathologically as yolk sac carcinoma. All children were less than 3 years old and 10 of 12 were less than 2 years old. Of the 12 cases 4 had positive lymph node dissections and 3 of these 4 children were less than 2 years old. Although chemotherapy is so effective its toxicity cannot be minimized. Therefore, adjunctive chemotherapy should be reserved for those patients who have lymphatic spread. Young children with yolk sac tumors are not immune to metastatic disease and should be treated with an extended unilateral lymphadenectomy for staging and appropriate treatment regimens.",
author = "Kaplan, {William E} and Firlit, {C. F.}",
year = "1981",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(17)54681-9",
language = "English (US)",
volume = "126",
pages = "663--664",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

Treatment of testicular yolk sac carcinoma in the young child. / Kaplan, William E; Firlit, C. F.

In: Journal of Urology, Vol. 126, No. 5, 01.01.1981, p. 663-664.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment of testicular yolk sac carcinoma in the young child

AU - Kaplan, William E

AU - Firlit, C. F.

PY - 1981/1/1

Y1 - 1981/1/1

N2 - The majority of testicular tumors in children will be of germ cell origin and the predominant pathologic type is the yolk sac carcinoma. Initial treatment of radical orchiectomy is not in question. However, because of its presumed less virulent character, especially in children less than 2 years old, confusion remains as to adjunctive treatment for yolk sac carcinoma. We have studied retrospectively 21 children with testis tumors encountered within the last 10 years. Of these cases 12 were classified pathologically as yolk sac carcinoma. All children were less than 3 years old and 10 of 12 were less than 2 years old. Of the 12 cases 4 had positive lymph node dissections and 3 of these 4 children were less than 2 years old. Although chemotherapy is so effective its toxicity cannot be minimized. Therefore, adjunctive chemotherapy should be reserved for those patients who have lymphatic spread. Young children with yolk sac tumors are not immune to metastatic disease and should be treated with an extended unilateral lymphadenectomy for staging and appropriate treatment regimens.

AB - The majority of testicular tumors in children will be of germ cell origin and the predominant pathologic type is the yolk sac carcinoma. Initial treatment of radical orchiectomy is not in question. However, because of its presumed less virulent character, especially in children less than 2 years old, confusion remains as to adjunctive treatment for yolk sac carcinoma. We have studied retrospectively 21 children with testis tumors encountered within the last 10 years. Of these cases 12 were classified pathologically as yolk sac carcinoma. All children were less than 3 years old and 10 of 12 were less than 2 years old. Of the 12 cases 4 had positive lymph node dissections and 3 of these 4 children were less than 2 years old. Although chemotherapy is so effective its toxicity cannot be minimized. Therefore, adjunctive chemotherapy should be reserved for those patients who have lymphatic spread. Young children with yolk sac tumors are not immune to metastatic disease and should be treated with an extended unilateral lymphadenectomy for staging and appropriate treatment regimens.

UR - http://www.scopus.com/inward/record.url?scp=0019789537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019789537&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(17)54681-9

DO - 10.1016/S0022-5347(17)54681-9

M3 - Article

C2 - 7299932

AN - SCOPUS:0019789537

VL - 126

SP - 663

EP - 664

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -